In the modern era, the cyberbullying (CB) is an intentional and aggressive action of an individual or a group against a victim via electronic media. The consequence of CB is increasing alarmingly, affecting the victim either physically or psychologically. This allows the use of automated detection tools, but research on such automated tools is limited due to poor datasets or elimination of wide features during the CB detection. In this paper, an integrated model is proposed that combines both the feature extraction engine and classification engine from the input raw text datasets from a social media engine. The feature extraction engine extracts the psychological features, user comments, and the context into consideration for CB detection. The classification engine using artificial neural network (ANN) classifies the results, and it is provided with an evaluation system that either rewards or penalizes the classified output. The evaluation is carried out using Deep Reinforcement Learning (DRL) that improves the performance of classification. The simulation is carried out to validate the efficacy of the ANN-DRL model against various metrics that include accuracy, precision, recall, and f-measure. The results of the simulation show that the ANN-DRL has higher classification results than conventional machine learning classifiers.
In recent time, data analysis using machine learning accelerates optimized solutions on clinical healthcare systems. The machine learning methods greatly offer an efficient prediction ability in diagnosis system alternative with the clinicians. Most of the systems operate on the extracted features from the patients and most of the predicted cases are accurate. However, in recent time, the prevalence of COVID-19 has emerged the global healthcare industry to find a new drug that suppresses the pandemic outbreak. In this paper, we design a Deep Neural Network (DNN) model that accurately finds the protein-ligand interactions with the drug used. The DNN senses the response of protein-ligand interactions for a specific drug and identifies which drug makes the interaction that combats effectively the virus. With limited genome sequence of Indian patients submitted to the GISAID database, we find that the DNN system is effective in identifying the protein-ligand interactions for a specific drug.
In this paper, a data mining model on a hybrid deep learning framework is designed to diagnose the medical conditions of patients infected with the coronavirus disease 2019 (COVID-19) virus. The hybrid deep learning model is designed as a combination of convolutional neural network (CNN) and recurrent neural network (RNN) and named as DeepSense method. It is designed as a series of layers to extract and classify the related features of COVID-19 infections from the lungs. The computerized tomography image is used as an input data, and hence, the classifier is designed to ease the process of classification on learning the multidimensional input data using the Expert Hidden layers. The validation of the model is conducted against the medical image datasets to predict the infections using deep learning classifiers. The results show that the DeepSense classifier offers accuracy in an improved manner than the conventional deep and machine learning classifiers. The proposed method is validated against three different datasets, where the training data are compared with 70%, 80%, and 90% training data. It specifically provides the quality of the diagnostic method adopted for the prediction of COVID-19 infections in a patient.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.